Roland W Sutter Selected Research

Inactivated Poliovirus Vaccine (Salk Vaccine)

10/2022	One Full or Two Fractional Doses of Inactivated Poliovirus Vaccine for Catch-up Vaccination in Older Infants: A Randomized Clinical Trial in Bangladesh.
1/2022	Intradermal administration of fractional doses of the inactivated poliovirus vaccine in a campaign: a pragmatic, open-label, non-inferiority trial in The Gambia.
1/2018	Evaluation of vaccine derived poliovirus type 2 outbreak response options: A randomized controlled trial, Karachi, Pakistan.
1/2018	Cuba's Scientific Contributions to Global Polio Eradication.
1/2017	Intradermal Administration of Fractional Doses of Inactivated Poliovirus Vaccine: A Dose-Sparing Option for Polio Immunization.
1/2017	Immunogenicity to poliovirus type 2 following two doses of fractional intradermal inactivated poliovirus vaccine: A novel dose sparing immunization schedule.
12/2015	Immunogenicity of a new routine vaccination schedule for global poliomyelitis prevention: an open-label, randomised controlled trial.
10/2015	Needle-free jet injector intradermal delivery of fractional dose inactivated poliovirus vaccine: Association between injection quality and immunogenicity.
11/2014	The new polio eradication end game: rationale and supporting evidence.
9/2014	Reactogenicity and immunogenicity of inactivated poliovirus vaccine produced from Sabin strains: a phase I Trial in healthy adults in Cuba.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Roland W Sutter Research Topics

Disease

60	Poliomyelitis (Polio) 10/2022 - 01/2002
5	acute flaccid myelitis 01/2022 - 01/2008
5	Infections 05/2012 - 04/2007
4	Malnutrition (Nutritional Deficiencies) 01/2018 - 11/2014
4	Paralysis (Palsy) 08/2015 - 01/2002
2	Primary Immunodeficiency Diseases 01/2017 - 12/2012
2	Measles 05/2003 - 08/2002
1	COVID-19 09/2021
1	Growth Disorders 09/2017
1	Vaccine-Preventable Diseases 03/2016
1	Blister (Bulla) 10/2015
1	Polyneuropathies (Polyneuropathy) 01/2013
1	Common Variable Immunodeficiency 12/2012
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 12/2012
1	Enterovirus Infections 05/2012
1	Rubella (German Measles) 05/2003
1	Diphtheria 08/2002
1	Tetanus 08/2002

Drug/Important Bio-Agent (IBA)

43	VaccinesIBA 01/2022 - 01/2002
24	Oral Poliovirus Vaccine (Sabin Vaccine)IBA 10/2022 - 10/2004
13	Inactivated Poliovirus Vaccine (Salk Vaccine)FDA Link 10/2022 - 01/2004
12	Poliovirus VaccinesIBA 09/2017 - 08/2002
6	AntibodiesIBA 01/2018 - 06/2007
2	Antiviral Agents (Antivirals)IBA 01/2017 - 01/2017
2	Neutralizing AntibodiesIBA 01/2017 - 01/2017
1	Viral ProteinsIBA 01/2018
1	insulin receptor-related receptor (IRR)IBA 01/2017
1	Capsid Proteins (Capsid Protein)IBA 05/2014
1	Immunoglobulin A (IgA)IBA 05/2014
1	SuspensionsIBA 05/2014
1	ExotoxinsIBA 01/2013
1	Vitamin A (Retinol)FDA LinkGeneric 12/2010
1	Hazardous Substances (Hazardous Materials)IBA 12/2006
1	Rubella VaccineIBA 05/2003
1	Measles VaccineIBA 05/2003
1	Immunoglobulin G (IgG)IBA 05/2003
1	ToxoidsIBA 08/2002
1	Pertussis VaccineIBA 08/2002

Therapy/Procedure

1	Immunotherapy 01/2017
1	Mechanical Ventilators (Ventilator) 01/2013
1	Injections 04/2003